0001193125-23-149304 Sample Contracts

4,496,744 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) PRE-FUNDED WARRANTS TO PURCHASE 12,895,256 SHARES OF COMMON STOCK PRELUDE THERAPEUTICS INCORPORATED UNDERWRITING AGREEMENT
Prelude Therapeutics Inc • May 19th, 2023 • Pharmaceutical preparations • New York
Company
Filed
May 19th, 2023
Industry
Jurisdiction